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Abstract Subceilular distribution of heterotrimerie GTP-bind- 
ing proteins during thrombin receptor-mediated platelet activa- 
tion was examined, revealing two phases of translocation to the 
cytoskeleton. A part of Gi2a and Gse~ shows first phase 
transloeation to the low-speed pellet (15000 x g pellet) within 
1 rain after activation, suggesting involvement in platelet shape 
change or granule secretion. In the second phase, Gi2~ Gs~ 
Gq~ and GJ3 translocate to the low-speed pellet, depending on 
phtelet aggregation. These transloeations correlated with the 
reorganization of the aetin-eytoskeleton a d were Inhibited by 
eytoehalasin D. Reconstitution experiments also revealed that G 
proteins are associated with the aetin-eytoskeleton during 
platelet activation. 
Key words: Platelet activation; Cytoskeleton; G protein; 
p60c-src; OPIIbIIla 
1. Introduction 
Platelets respond to several agonists, resulting in rapid 
shape change, granule secretion and aggregation. The platelet 
is, therefore, a suitable cell to assist understanding of the 
transmembrane signal transduction. Numerous intracellular 
molecular events during platelet activation have been re- 
ported: enhancement of phosphatidylinositol turnover and 
their key enzymes, increasing Ca 2+ influx, elevation of tyro- 
sine kinase activities, and reorganization of the cytoskeleton 
[1-4]. Of particula r interest is the finding that several signal 
transducing molecuk's uch as p60 c-"rc, phosphatidylinositol- 
3-kinase, phosphatidylinositol-4-kinase, phosphatidylinositol- 
4,5-kinase, diacylgycer~! kinase, pilospholipase C, phospho- 
lipase A2, and small GTP-binding proteins, rap I B, rap 2B, 
rho, rac, and cdc42Hs [5-8] translocate to the reorganized 
cytoskeleton during the activation processes. These findings 
suggest hat the platelet cytoskeleton may act as a functional 
network connecting signal transducing molecules. However, 
the significance of such connection remains unclear. 
Heterotrimeric GTP-binding proteins (G proteins) cola- 
posed of ~, 6, and y subunits are involved in transmembrane 
signal transduction i  a variety of ~:ells. In platelets, a family 
of G proteins has been reported to mediate inhibition of ade- 
nylyl cyclase, and activation of phospholipase C and phos- 
pholipase A2 [9]. There is, however, no information regarding 
*Corresponding author. Fax: (81) (6) 879-3689. 
Abbreviations: G protein, guanine nucleotide-binding protein; GP, 
glycoprotein; DTT, dithiothreitol; SDS-PAGE, sodium dodecyl 
sulfate-polyacrylamide gel lectrophoresis. 
the cytoskeletal connection of G proteins in platelets. In this 
paper, we performed sequential nalysis of G protein translo- 
cation during thrombin receptor-mediated platelet activation. 
As a result, we obtained the first evidence that G proteins 
display phase-specific translocation to the actin-based cyto- 
skeleton; translocation of (3i2o~ and Gso~ correlates well with 
the reorganization of the actin-based cytoskeleton causing a 
shape change, and translocation of Gqt~, G[t, Gi2a, and Gstx 
is associated with platelet aggregation. 
2. Materials and methods 
2.1. Materials 
Anti-G protein antisera, ASI7, RM/I, QL, and SWll were pur- 
chased from Du Pont. Monoclonal antibody against p60 v-"re was 
purchased from Oncogene Science. Monoclonal anti-GPIIb antibody, 
which can be applied to immunoblotting under nonreducing condi- 
tions, was produced and provided by Seikagaku Corporation (Tokyo, 
Japan). Thrombin receptor (TR) peptide, SFLLRN, was synthesized 
by the solid-phase synthesis technique [10]. Cytochalasin D and de- 
oxyribonuclease I (DNase I) were purchased from Sigma. RGDS 
peptide was obtained from Peptide Institute. Actin was prepared 
from rabbit skeletal muscle by the method of Spudich and Watt 
[11], and finally purified by gel filtration. 
2.2. Preparation of human platelets 
Washed human platelets were prepared as described [12] and finally 
suspended in 140 mM NaCl, 2.5 mM KCI, 0.1 mM MgCl2, i mM 
CaCI2, I0 mM NaHCOa, 0.5 mM NaH2PO4, 0.1% glucose, and 
I0 mM HEPES (pH 7.4) at 5×10S/ml and incubated at 37°C for I h 
prior to experiments. 
2.3. Platelet activation and subceilular fractionation 
Platelet aggregation was monitored by a lumi.aggregometer model 
560-VS (Chrono-log). ATP secretion was monitored with luciferin- 
luciferase reagent (Chrono-log). Platelets were activated with 40 ~tM 
TR peptide at 37°C with or without constant stirring at 1000 rpm. In 
some experiments, platelets were preincubated with 0.5 mM RGDS 
peptide or 10 p.g/ml cytochalasin D before activation. At indicated 
times, aliquots of activated platelets were lysed with half volume of 
ice-cold lysis buffer (3% Triton X-100, 150 mM Tris-HCi (pH 7.5), 
15 mM EGTA, 75 ~M 4.amidinophenylmethylsuifonyl luoride (p- 
APMSF), 1.5 mM diisopropyl f uorophosphate (DFP), 30 I~g/ml leu- 
peptin, 0.35 U/ml aprotinin). Subcellular f actionation was performed 
according to the well-established method of Fox et al. [i 3] with minor 
modifications. The lysate was kept on ice for 10 min, and then cen- 
trifuged at 15000 × g for 10 rain to obtain the low-speed pellet. The 
supernatant was further centrifuged at ! 20 000 × g fo, 2 h to separate 
the high-speed pellet and the supernatant. 
2.4. Actin-binding assay 
The low-speed pellet as described above was sonicated with hypo- 
tonic buffer (0.2 mM Tris-HC! (pH 8.0), 0.2 mM EDTA, 0.1 mM 
DTT, 0.05% Triton X-100, 75 ~M p.APMSF, !.5 mM DFP, 30 9g/ 
ml leupeptin, 0.35 U/ml aprotinin) and dialyzed during overnight 
against he same buffer. The hypotonic extract and actin monomer 
(0.3 mg/ml) were mixed in the presence or absence of 0.4 mg/ml 
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Fig. I. lmmunoblotting of bovine brain membrane and human pla- 
telets with anti-O protein antisera. Bovine brain membrane (lane I) 
and human platelets (lane 2) were subjected to 12,5% SDS-PAGE 
and electrophoretically transferred :o nitrocellulose membranes. The 
blots were probed with 1:400 dilution of AS/7 (Gi2a, A), RM! 
(Osa, B), QL (Gqa, C), or SWII (O6, D). Positions of molecular 
weight standard are indicated in kD on the left. 
DNase I. The buffer conditions were as follows: 20 mM MES (pH 
7.0), 50 mM NaCI, 2 mM MgCI2, I mM EGTA, 0. !mM DTT, 0.05% 
Triton X-100. After incubation at 37eC for 30 rain, the mixture was 
centrifuged at 100000 × g for 30 rain. The supernatants and the pellet~ 
were examined for the contents of G proteins by immunoblotting. 
Time 
Fraction 
ABP~ 
MHO ~-  
a-actlnln ~ 
2.5. Others 
SDS-PAGE was performed in the presence or absence of 2-mercap- 
toethanol by the method of Laemmli [14]. lmmunoblotting was per- 
formed as described [12]. Proteins were detected using enh,mced 
chemiluminescence system (Amersham). The blots were scanned 
with a flying-spot scanner model CS-9000 (Shimadzu, Kyoto). 
3. Results 
The specificity of the antisera used in this study was exam- 
ined by immunoblotting (Fig. 1). In our experiments, AS/7, 
which recognizes Gilot and Gi2ct, reacted with a 41 kDa pro- 
tein in human platelets (Fig. I A, lane 2). It has been reported 
that platelets express all of the three members of Giot subunits 
[15]. Considering the prominence of Gi2a in platelets 
(Oi2a>>Gi3(x>Oi l (x)  [15] and the results of two-dimen- 
sional electrophoresis of human platelets followed by immu- 
noblotting with ASI7, we regarded the 41 kDa protein as 
Gi2a. RMI ;  serum against Gsa recognized a 45 kDa band 
in platelets (Fig. I B, lane 2), indicating that the, 45 kDa form 
of Gsu is dominant in platelets. QL serur~, specific for Gqa  
and G I la ,  reacted with a 42 kDa ban(] and an additional 
faint band with a lower molecular mass in platelets (Fig. 
IC, lane 2). As an undetectable amount of G I la  is expressed 
in platelets [16], the 42 kDa band represents Gqa exclusively. 
SWII serum against common G~ recognized a 35 kDa band 
in human platelets (Fig. I D, lane 2). 
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Fig. 2. Time-course of translocation of cytoskdetal proteins, G proteins, p60 c-m, and GPllb to the cytoskeleton during ~latelet activation. Pla- 
telets were activated with 40 I~M thrombin receptor peptide and aliquots of platelets were lysed with ice-cold lysi~" buffer at 5 s, 15 s, 30 s, 45 s, 
I rain, 2 rain, 3 rain, and 5 rain after activation. The sample designated as 0 s was lysed before addition of TR peptide. The lysate was fractio- 
hated into supematant (lane I), the low- (lane 2), and the high-speed pellet (lane 3) as described in section 2. Each fraction was separated by 
10% SDS.PAGE and stained with Coomassie brilliant blue (upper panel) or electrophoretically transfe.n'ed to nitro,.:ellulose membranes, fol- 
lowed by immunoblotting with 1:400 dilution of AS/'/(Gi2a), RMII (Gsa), QL (Gqa), SW/I (G~), I : 30 dilution of anti-p60 ..... antibody 
(p60c-"~), or I : I00 dilution of anti-GPllb-llla ntibody (GPIIb). 
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Fig. 3. Comparison of the kinetics of platelet aggregation, ATP se- 
cretion, and translocation of G proteins, p60 '-"r', Gpllb. (A) Plate- 
let aggregation and ATP secretion was monitored in the same ex- 
periment. 100% aggregation was defined as the light transmission at 
5 min. ATP secretion was monitored as described in section 2.3. 
(B) The percentage of Gi2a (O--O), Gsa (e--O), Gqa (z~--z~ ), G[5 
(m--i), p60 e ..... (E~C]), and GPllb (A--A) in the low-speed pellet 
was determined by densi~metric scanning of immunoblots. The data 
presented are a representative r sult of at least 6 separate xperi- 
ments. 
It has been shown that thrombin receptor is activated by a 
novel mechanism involving proteolytic leavage and tethered 
ligand formation [17]. A synthetic peptide with the sequence 
SFLLRN has been shown to be a potent stimulant of the 
receptor, and causes platelet activation [18]. In our prelimin- 
ary experiments, 40 pM TR peptide was roughly equivalent to 
0.1 Ulml thrombin with respect o induce platelet aggregation 
(data not shown). We used the peptide as an agonist and 
examined the subcellular distribution of G proteins during 
platelet activation. 
The upper panel of Fig. 2 shows the subcellular distribution 
of platelet proteins during activation. In resting platelets (0 s), 
only a trace amount of actin was found in the low-speed 
pellet. At 5 s after activation, a significant amount of actin 
and a.actinin translocated to the low-speed pellet. At 15 s, 
actin-binding protein (ABP or filamin) and myosin heavy 
chain were detectable in the low-speed pellet. Thereafter, the 
contents of actin, myosin, ABP, and a-actinin in the low- 
speed pellet gradually increased until 2 rain. In the low-speed 
pellet, these cytoskeletal proteins were the most abundant. 
The subcellular distribution of these proteins eems to remain 
unchanged subsequently. 
All G proteins examined also translocated to the low-speed 
pellet (Fig. 2 bottom panels); however, they were categorized 
into two groups with respect o the pattern of translocation. 
The first group consists of Gi2a and Gsa; the second Gqa 
and GI3. In resting platelets, Gi2a and Gsa were recovered in 
both the supern~tant a,d the high-speed pellet. At 5 s after 
activation, small amounts of both Gi2a and Gsa could be 
detected in the low-speed pellet. The amounts of Gi2a and 
Gsa in the low-speed pellet increased between 45 s and 2 rain, 
at which time Gi2a and Gsa were predominant. On the other 
hand, Gqa and G~ distributed mainly in the supernatant of 
resting platelets. Both G protein subunits were not detected in 
the low-speed pellet until 45 s after activation. Significant 
amounts of both Gqa and GI] were detected in the low-speed 
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Fig. 4. Effect of RGDS peptide or cytochalasin D on the transloca- 
tion of G proteins during platelet activation. Platelets were preincu- 
bated with 0.5 mM RGDS peptide (5) or l0 ~g/ml cytochalasin D
(4) and activated with 40 pM TR peptide with (I-5) or without (6) 
stirring. At 0 s (1), 15 s (2), or 3 rain (3-6), pla~elets were lysed and 
fractionated into supernatant (black column), the low.speed pellet 
(open column), and the high-speed pellet (shaded column). The con- 
tents of Gi2a (A), Gsa (B), Gq~ (C), and GJ3 (D) in each fraction 
were determin~:t by immunoblotting followed by densitometric s an- 
ning. The vertical axis indi.o,~tes percent distributio',, of individual 
subunits. The data presented are a typical result of at least 6 sepa- 
rate experiments. 
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Fig. 5, Actin.binding assay of hypotonic extract from the low-speed 
pellet. Hypotonic extract of the low-speed pellet prepared as de- 
scribed in section 2 was incubated with (2,3) or without (!) 0.3 rag/ 
ml of actin in the presence (3) or absence (!,2) of 0.4 mg/ml DNase 
I, and separated into 100000×g supernatant (S) and pellet (P). Ira- 
munoblotting was performed with !:400 dilution of AS/7 (Gi2cz), 
RMll (Gin), QL (Oq00, or SWll (GI]). 
pellet after 2 min. p60 c-src and GPllbllla showed a transloca- 
tion pattern similar to that of Gqa and G~. The present 
results indicate that (3i2a and Gsa translocate to the low- 
speed pellet at an early stage, followed by further transloca- 
tion in the late stage, while (3qot and Gsa translocated to the 
low-speed pellet only in the late stage of activation. 
To assess the significance of (3 protein transiocation to the 
cytoskeleton i  platelet function, we qum,tified the relative 
contents of (3 proteins, p60o -~,  and GpIIb in the low-speed 
pellet by scanning the blots of Fig. 2 (Fig. 3B). The percent 
distributions of Gi2a and Gs~ in the low-speed pellet reached 
a plateau within 1 rain after activation, while Gqa, G~, 
p~=~,  and (3pllb were gradually increased uring this per- 
iod. All proteins howed marked increases after I rain, reach- 
ing a second plateau at about 2 or 3 rain. The first peak of 
Gi2a and Osa corresponded to maximal ATP secretion (Fig. 
3A). Platelets also changed shape within seconds after activa- 
tiot. 'Fhe~e results suggest hat rapid translocation of (3i2(x 
and (3sa Io the cytoskeleton is associated with platelet shape 
chaotic and/or granule secretion, The second peak of all pro- 
teins coincided with platelet aggregation, suggesting an asso- 
ciation betw~n translocation i the second peak and platelet 
aggregation, It is noted that the extent of translocation dif- 
fered between proteins, About 70-80OA of (3i2a and Gs(x was 
in the low-speed pellet at 5 min, compared to approximately 
50°/5 of O~ and I)6(F =~ and about 20% of Gq(z and (3pllb, 
These differences were reproducible with 4 different experi- 
ments, and suggest hat translocation of G proteins to the 
low-speed pellet is mediated by some specific interaction 
with their targets, not an artificial phenomenon such as trap- 
ping by fibrin clots. 
We then characterized the translocation of (3 proteins. 
(3Pllbllla (allbp3 integrin) is essential for platelet aggrega- 
tion, When GPllblila ligation and subsequent platelet aggre- 
gation were inhibited by preincubation with RGDS peptide 
(Fig. 4, column 6) or activation without stirring (Fig. 4, col- 
umn 5), the second phase translocation of G proteins to the 
low-speed pellet was .¢~tppressed compared with aggregated 
platelets (Fig. 4, column 3). The subcellular distribution of 
G proteins under these conditions was comparable to that 
normally seen at 15 s .'~ aggregated platelets (Fig. 4, column 
2). The result indicates that translocation of G proteins to the 
low-speed pellet shows two phases which are clearly di:,tin- 
guished by GPIIbIIla dependency. Here, we defined these 
two phases of translocation: the first phase translocation oc- 
curs within 15 s after activation, independent of GPIIbIIla 
engagement; whereas the second phase translocation begins 
at around 1 min and is strictly dependent on GPIIbIIIa. Cy- 
tochalasin D, which inhibits actin polymerization, suppressed 
the first phase translocation of Gi2a and Gsa (Fig. 4 column 
4) as well as actin (data not shown). Thus, the first phase 
translocation is dependent on actin polymerization or expo- 
sure of barbed ends of actin filaments, suggesting the associa- 
tion of {3 proteins with the actin-based cytoskeleton. 
In order to confirm the interaction of G proteins with the 
actin-based cytoskeleton, a reconstitution assay was per- 
formed. Immunoblotting and SDS-PAGE revealed that the 
hypotonic extract of the low-speed pellet at 3 min after acti- 
vation contains ¢3 proteins as well as cytoskeletal proteins 
such as actin, ABP, and 0~-actinin (data not shown), (3 pro- 
teins in the extract were co-precipitated with exogenously 
added actin (Fig, 5, lane 2). Preincubation with DNase l, 
which induces depolymerization f actin :~laments, completely 
inhibited sedimentation f (3 proteins (Fig. 5, lane 3). In the 
absence of exogenous actin, neither (3 proteins nor actin was 
precipitated, probably because the concentration of actin in 
the final assay mixture was lower than the critical concentra- 
tion (Fig. 5, lane I). This result suggests that (3 proteins in the 
low-speed pellet are associated with the actin-based cytoskel- 
eton. 
4. Discussion 
Differential centrifugation analysis of Triton X-100-treated 
platelet lysates is a useful and well-estabfished meth(~d to ex- 
amine and characterize the reorganization of the platelet cy- 
toskeleton [5,13]. The low-speed pellet is taough~ to 0e com- 
posed of a network of actin filaments a~ld their associated 
proteins. The high-sl~d pellet is proposed to represent the 
membrane cytoskeleton i cluding filamentous actin and asso- 
ciated proteins. In resting platelets, cytoplasmic actin fila- 
ments are not sufficiently cross-linkeG and recovered in the 
high-speed pellet, contrary to the low-speed pellet [5] (~ig. 
2). After activation, actin filaments are rapidly cross-linked 
resulting in an increased sedimentation i  the low-speed 
pellet, e~-Actinin, A~P, and tropomyosin are also in~reased 
in the low-speed pellet. The aggregation-independent firs
phase translocation of (3i2qz and (3set is quite similar to trans- 
location of those cytoskeletal proteins, suggesting that this 
pool of Gi2ot and (3se~ is associated with cytoplasmic actin 
filaments. It is possible that (3i2cz and (3set are localized at the 
site where the cytoplasmic actin filaments terminate at the 
plasma membrane, and are a~aociated with the reorganization 
of the eytoskeleton i an ~arly phase of platelet activation. 
The second phase transiocation of G proteins is associated 
with platelet aggregation, which is a typical example of integ- 
rin-mediated cell adhesion. It is possible to consider that a 
multimolecular cell adhesion apparatus which links GPIIbIIIa 
to the actin-cytoskeleton is formed in aggregated platelets as 
seen in focal contacts of cultured cells [19]. Proteins which are 
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recovered in the low-speed pellet in the second phase, includ- 
ing G proteins and p60 c-~rc, may be involved in the formation 
or maintenance of the cell adhesion apparatus. In this regard, 
it is of interest hat ~ subunit has been shown to be localized 
with vinculin at the focal adhesion of cardiac fibroblasts [20]. 
It is possible that G proteins are generally involved in the 
integrin-mediated cell adhesion in association with the actin- 
based cytoskeleton. 
G proteins transduce signals from receptors to the appro- 
priate effectors. In platelets, Gia has been shown to inhibit 
adenylyl cyclase activity during platelet activation. Gs stimu- 
lates adenylyl cyclase activity; however, the significance of 
Gscz in platelet activation remains unclear. Gq, a member of 
another family of G proteins (Gq/GII family), has been 
shown to activate phospholipase C[3 [21]. Thrombin receptor 
functionally couples with Gi. Further, Gq/l 1, GI2, and GI3 
are also activated via thrombin receptor [22]. Recent under- 
standing of G protein function indicates that both ¢z and [IV 
subunits which are dissociated upon receptor activation reg- 
ulate specific effectors [23]. At present it is unclear whethc~- 
cytoskeleton-associated a and [~ subunits bind to the same 
cytoskeletal protein in the trimeric state or bind to different 
proteins, or whether cytoskeletal association of G proteins 
reflects the activation of individual G proteins. Translocation 
of Gi2ot and Gsa, but not G[I, in the first phase (Figs. 2 and 
3) suggests that (x subunits of Gi2 and Gs dissociated from ~y 
subunits independently translocate to the low-speed pellet. 
Further examination of this problem is required. 
Association of G proteins with the cytoskeleton has also 
been reported in neutrophils, Sf49 mouse lymphoma cells, 
and cardiac fibroblasts [20,24,25]. Gq/GI 1 a subunits have 
been recently shown to associate with actin filaments in 
WRKI cells [26]. As G protein does not directly bind F-actin, 
it is likely that the cytoskeletal association of G proteins is 
mediated by certain cytoskeletal proteins. Recently, a number 
of signal transducing molecules have been shown to transio- 
cate to the cytoskeleton during platelet activation. These in- 
clude p60 c-~rc, p62~-Y% phosphatidylinositol-3 kinase, phos- 
pholipase A2, phospholipase C, GTPase activating protein, 
protein kinase C, p125 FAK, raplB, rap2B, rho, rac, and 
cdc42Hs. Stimulation of G protein-coupled receptor activates 
multiple signalling cascades, including tyrosine kinases, phos- 
pholipase C, and Ras pathway [27]. The cytoskeleton may 
provide the site where these signal transducing molecules, in- 
cluding G proteins, assemble and interact with each other, 
resulting in cross-talk of signalling pathways. Alternatively, 
the cytoskeleton may be directly invc'ved in the G protein- 
mediated signal transducing events. It has been reported that 
caispectin (fodrin or non-erythroid spectrin) modulates the 
activity of CD45, a transmembrane protein tyrosine phospha- 
tase [28]. Similar regulation may be present in G protein- 
mediated signalling. In order to examine these possibilities, 
it is important to examine the cytoskeletal target of G proteins 
and how the interaction is regulated. Investigation iscurrently 
underway to identify G protein-binding protein(s) in the acti- 
vated platelet cytoskeleton. 
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